Literature DB >> 4511938

Lysozyme activity and nitroblue-tetrazolium reduction in leukaemic cells.

D Catovsky, D A Galton.   

Abstract

The cytochemical methods for lysozyme and nitroblue-tetrazolium reduction have been used to study the blast cells of acute myeloid leukaemia. Both proved useful in characterizing the cases with predominant monocytic differentiation. THE DEMONSTRATION OF LYSOZYME ACTIVITY HELPED TO DEFINE TWO MAIN GROUPS: (a) with predominantly lysozyme-negative cells (myeloblastic-promyelocytic), and (b) with considerable numbers of positive cells (monoblastic-monocytic). In addition this test was also of value in the differentiation of other leukaemic disorders. Reduction of nitroblue-tetrazolium was also a feature of monocytic differentiation. The combination of these two methods with those for myeloperoxidase and non-specific esterase activity contributes to the cytological characterization of acute myeloid leukaemia.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4511938      PMCID: PMC477651          DOI: 10.1136/jcp.26.1.60

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Identification of blood monocytes by demonstration of lysozyme and peroxidase activity.

Authors:  E Syrén; A M Raeste
Journal:  Acta Haematol       Date:  1971       Impact factor: 2.195

2.  N.B.T. test stimulated.

Authors:  H H Park; R A Good
Journal:  Lancet       Date:  1970-09-19       Impact factor: 79.321

3.  [I. Specific esterases of monocytes: their use in the classification of acute leukemias].

Authors:  M T Daniel; G Flandrin; F Lejeune; P Liso; P Lortholary
Journal:  Nouv Rev Fr Hematol       Date:  1971 Mar-Apr

4.  Infection and nitroblue-tetrazolium reduction by neutrophils. A diagnostic acid.

Authors:  B H Park; S M Fikrig; E M Smithwick
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

5.  Immunocytological demonstration of lysozyme (muramidase) in human leukaemic cells.

Authors:  H Asamer; F Schmalzl; H Braunsteiner
Journal:  Br J Haematol       Date:  1971-06       Impact factor: 6.998

6.  Clinical significance of serum and urinary muramidase activity in leukemia and other hematologic malignancies.

Authors:  P H Wiernik; A A Serpick
Journal:  Am J Med       Date:  1969-03       Impact factor: 4.965

7.  [On the origin of monocytes].

Authors:  F Schmalzl; H Braunsteiner
Journal:  Acta Haematol       Date:  1968       Impact factor: 2.195

8.  Lysozyme in bone marrow and peripheral blood cells.

Authors:  R S Briggs; P E Perillie; S C Finch
Journal:  J Histochem Cytochem       Date:  1966-02       Impact factor: 2.479

9.  Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease.

Authors:  D G Nathan; R L Baehner; D K Weaver
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

10.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Enzyme cytochemistry of blood and marrow cells.

Authors:  J Stuart; P A Gordon; T R Lee
Journal:  Histochem J       Date:  1975-09

2.  Proceedings: Methods for the study and cell differentiation in acute leukaemia.

Authors:  D Catovsky
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.